RecallDepth
Class II Terminated

medroxyPROGESTERone Acetate Injectable Suspension, USP, 1 mL Prefilled Syringe, 150 mg/mL, Rx only, Manufactured by: Sun Pharmaceutical Industries, Ltd., Halol-Baroda Highway, Halol-389 350, Gujarat, India Distributed by: Afaxys Pharma, LLC, Charleston, SC, 29403, USA, Product of Italy, NDC 50102-591-40.

Company
Sun Pharmaceutical Industries Inc
Recall Initiated
May 6, 2022
Posted
June 22, 2022
Recall Number
D-1143-2022
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
79339 syringes
Firm Location
Princeton, NJ, United States

Reason for Recall

Lack of assurance of sterility

Distribution

USA Nationwide

Lot / Code Info

Lots#: JKX4312A & JKX4313A, Exp 09/2022; JKX4827A, Exp 09/2023; HAC1290A & HAC2082B, Exp 06/2023;

More recalls by Sun Pharmaceutical Industries Inc

View all recalls by this company →

Other recent Class II Drug recalls